 SALT LAKE CITY , May 2, 2022 PRNewswire -- Sera Prognostics Inc., The Pregnancy Company Nasdaq: SERA, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report first quarter fiscal year 2022 financial results on Tuesday, May 10, 2022, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. 